← All candidates
Eleven insider buys in the last year — $25.14M in all.
52 filings on record.
AUPHAurinia Pharmaceuticals Inc.
NasdaqGM · Healthcare · $2.18B
$16.13
-1.71% · Sep 15
Eleven insider buys in the last year — $25.14M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 11 buys● 2 sells◆ 2 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$2.18B
Float
129.2M
97% public
Short % float
Pro
Price / profit
7.2
Price / future profit
15.3
Price / sales
7.0
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Tang Kevin
Bought $10.12M on Aug 1 — 1,000,000 sh @ $10.12, held indirect, 9.1% of their stake.
2 of 2 positions beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
26 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
39 more transactions on Pro →Context
Wall St
$17.00 avg target
+5.4% vs today · 7 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$0.25 act+$0.05
Q4 '25$1.53 act+$1.31
Q3 '25$0.23 act+$0.07
Q2 '25$0.16 act+$0.01
Coverage
We Believe Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings Are A Poor Guide For Its ProfitabilitySimply Wall St. · 05-15Aurinia Pharmaceuticals Inc. Just Beat EPS By 28%: Here's What Analysts Think Will Happen NextSimply Wall St. · 05-09Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top EstimatesZacks · 05-07Does Aurinia’s Tang‑Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)?Simply Wall St. · 03-29
The file stays open
52 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice